Blog
Why I Bought Apple's New AirPods Max Headphones
Before Apple (NASDAQ: AAPL) announced AirPods Max, I was already interested. Ahead of their launch, rumors about the Apple-branded over-ear headphones were rampant. If the company could pull off a
Forget Day Trading! Buy and Hold These 3 Stocks
Trading stocks on a daily basis can be exhilarating, but it's a risky way to invest. Markets can turn on a dime and very few investors have generated a long-term competitive advantage day trading.
2 Hot Growth Stocks That Could Be Millionaire-Makers
The television show Who Wants to Be a Millionaire? features contestants who can win up to a million dollars -- in a matter of hours -- by answering a series of trivia questions. Earning a million
Is Costco Stock a Buy?
Costco (NASDAQ: COST), the world's third-largest retailer (as measured by revenue), has seen its business perform extremely well over the past 12 months. What first started out as consumers
3 Reasons EV Stocks Are Making Headlines
It seems that recently, electric vehicle companies have been making headlines constantly, and there are few reasons why these companies are increasingly popular with investors. Among the most
3 Stocks to Buy With Dividends Yielding More than 6%
Interest rates may be up from the lows they hit in the middle of last year, when the novel coronavirus pandemic was raging. But with rates not too much improved from those record lows, overall stock
Is CRISPR Therapeutics Stock Poised to Soar Nearly 30%?
Gene-editing leader CRISPR Therapeutics (NASDAQ: CRSP) has generated sizzling returns for investors over the last 12 months. But one analyst thinks the biotech stock can go much higher. In this
5 Reasons I Just Bought More Naspers Stock
Readers may know I'm a fan of Naspers (OTC: NPSNY), an international stock that may be unfamiliar to some U.S. investors. After cashing in some high-flying value stocks that have soared recently, I
How This SaaS Company Is Going to Use $490 Million in SPAC Proceeds
Property technology and software-as-a-service (SaaS) company Latch is set to go public through a merger with blank-check company TS Innovation Acquisitions (NASDAQ: TSIA). And like most SPAC
3 Great Reasons to Delay Social Security as Long as You Can
When it comes to claiming Social Security, you have a range of ages to choose from. You could sign up for benefits at the earliest possible age of 62, but if you go that route, you'll shrink your
5 Brand-Name Stocks With 12-Year Winning Streaks
Over the long run, the stock market is the greatest wealth creator on the planet. Since 1980, the benchmark S&P 500 has delivered an average annual total return (i.e., including dividends) of more
3 ETFs That Could Triple the Average $3,061 Tax Refund
Filing your taxes may be a headache, but for a lot of taxpayers it results in a substantial windfall. The average tax refund was $3,061 for the week that ended March 5, according to the IRS.
These COVID Stocks Could Be Hurt by a Global Raw Material Shortage
COVID-19 vaccine production continues to increase to vaccinate Americans. However, there are some looming challenges in much of the rest of the world with a global raw material shortage. In this
Here's Warren Buffett's Cost Basis for Berkshire Hathaway's 10 Largest Holdings
Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett is arguably the greatest investor of our time. Rather than relying on fancy charting software or throwing his weight around as an
Is Gilead Sciences Stock a Buy After 2 Recent Wins?
Gilead Sciences (NASDAQ: GILD) hasn't generated excitement among investors in quite a while. However, the big biotech reported two new developments recently that at least hold the potential to boost
4 Pharma Stocks That Could Be Losers With the $1.9 Trillion Stimulus Package
Major government spending bills tend to create both winners and losers. The $1.9 trillion stimulus bill recently passed by Congress and signed into law by President Joe Biden is no exception. In
Better COVID Stock: Moderna vs. Pfizer
Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) were the first to win U.S. Emergency Use Authorization (EUA) for their respective COVID-19 vaccines. This success has made Moderna a huge winner for
Some Countries Suspended AstraZeneca's COVID Vaccine. Here's What Investors Need to Know.
It's fair to say AstraZeneca (NASDAQ: AZN) is a major player in the coronavirus vaccine market. More than 50 countries have authorized its vaccine. But in recent weeks, woes have been multiplying
1 Critical Choice to Protect Your Investment Returns
While putting as much money as possible into the stock market can seem exciting, setting aside money in an emergency fund is not something to overlook. In fact, if you have an emergency fund, all of
Before You Buy Biogen, Stop and Consider These 3 Things
When you think of the word "biotech," Biogen (NASDAQ: BIIB) may be one of the first companies to come to mind. The biotech giant has grown annual profit more than 200% to more than $4 billion over
3 Smart Ways to Invest Your $1,400 Stimulus Check
A fresh round of stimulus payments should be hitting recipients' bank accounts right about now. And if you're in line for a check in the mail, sit tight -- it could arrive in a matter of weeks.
Of
Forget Crypto: These Blazing-Hot Value Stocks Are Much Better Buys
For much of the past year, equity investors have had reason to smile. Since hitting a bear market bottom on March 23, the benchmark S&P 500 has risen by 76%, while the tech-heavy Nasdaq Composite
3 Unstoppable Vanguard ETFs That Can Make You Rich
You don't have to be an expert investor to get rich in the stock market. In fact, you don't even need to be great at picking stocks.
Investing in exchange-traded funds (ETFs) can be a great option
Calithera Biosciences Inc (CALA) Q4 2020 Earnings Call Transcript
Image source: The Motley Fool.
Calithera Biosciences Inc (NASDAQ: CALA)Q4 2020 Earnings CallMar 16, 2021, 5:00 p.m. ET
Operator
Source Fool.com
SMTP (SHSP) Q4 2020 Earnings Call Transcript
Image source: The Motley Fool.
SMTP (NASDAQ: SHSP)Q4 2020 Earnings CallMar 16, 2021, 4:30 p.m. ET
Operator
Source Fool.com


